Nanobiotix S.A. (NBTX)
NASDAQ: NBTX · Real-Time Price · USD
20.99
-0.18 (-0.85%)
At close: Jan 16, 2026, 4:00 PM EST
20.96
-0.03 (-0.14%)
After-hours: Jan 16, 2026, 5:16 PM EST
Nanobiotix Market Cap
Nanobiotix has a market cap or net worth of $1.04 billion as of January 16, 2026. Its market cap has increased by 629.44% in one year.
Market Cap
1.04B
Enterprise Value
1.06B
1-Year Change
629.44%
Ranking
Category
Stock Price
$20.99
Market Cap Chart
Since the IPO on November 21, 2016, Nanobiotix's market cap has increased from $249.91M to $1.04B, an increase of 314.96%. That is a compound annual growth rate of 16.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 1.04B | -6.37% |
| Dec 31, 2025 | 1.11B | 646.33% |
| Dec 31, 2024 | 148.41M | -57.08% |
| Dec 29, 2023 | 345.77M | 156.45% |
| Dec 30, 2022 | 134.83M | -53.41% |
| Dec 31, 2021 | 289.40M | -50.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 21, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 291.69B |
| Novartis AG | 276.38B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 268.23B |